Author: Fabien Pamelard

• 

  Fluidigm announces collaboration agreement with Imaging CRO ImaBiotech to increase biopharma access to Imaging Mass Cytometry

• 

  Following toxicity and efficacy markers in skin substructures using Mass Spectrometry Imaging (MSI)

• 

  Metabolomics and Metabolite Profiling using Mass Spectrometry Imaging (MSI): A New Biochemical Tool for Drug Discovery

• 

  Quantitative Mass Spectrometry Imaging (QMSI) of endogenous insulin in mouse pancreas using modified Insulin